Blue Cross and Blue Shield health insurance companies say they will join nonprofit drug maker Civica Rx’s effort to make and sell cheaper versions of insulin at more than $30 per vial.
Blue Cross Plans Will Back Nonprofit Drug Maker’s Cheaper Insulin
